Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users

Psychopharmacology
Jörg DaumannEuphrosyne Gouzoulis-Mayfrank

Abstract

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is neurotoxic in animal studies and its use has been associated with cognitive impairments in humans. To study hippocampal activation during the retrieval from episodic memory in polyvalent users of ecstasy. Twelve polyvalent ecstasy users and twelve matched controls were examined by means of functional magnetic resonance imaging (fMRI) while they retrieved face-profession associations from episodic memory. Ecstasy users had a normal structural MRI scan without focal brain lesions or anatomical abnormalities. They exhibited equal retrieval accuracy during memory retrieval to that of the matched controls. Yet, their retrieval-related activity was lower and more spatially restricted in the left anterior hippocampus than that of the controls. These results provide evidence for abnormal hippocampal functioning in MDMA users even at the presence of normal memory performance. This finding may be linked to MDMA-induced neurotoxicity and suggests that diminished hippocampal activation during memory retrieval might be a more sensitive or earlier index of MDMA-related neurotoxicity than neuropsychological performance.

References

Jan 1, 1997·Hippocampus·K HenkeH G Wieser
Aug 27, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M J Morgan
Dec 17, 1998·Neurology·K I BollaG A Ricaurte
Aug 5, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E Gould
May 16, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·E Gouzoulis-MayfrankH Sass
May 23, 2000·Annals of Medicine·M C BuhotL Segu
Jun 1, 2000·British Journal of Psychology·M WareingP N Murphy
Aug 17, 2000·The New England Journal of Medicine·S Y BookheimerG W Small
Aug 25, 2000·Psychopharmacology·J Rodgers
Feb 24, 2001·Psychopharmacology·R J VerkesA F Cohen
Sep 7, 2002·Applied Neuropsychology·Konstantine K ZakzanisNasim F Radkhoshnoud
Mar 6, 2003·Consciousness and Cognition·Katharina HenkeAlfred Buck
Apr 23, 2003·Brain Research. Cognitive Brain Research·Jörg DaumannEuphrosyne Gouzoulis-Mayfrank
Aug 19, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Euphrosyne Gouzoulis-MayfrankJoerg Daumann
Dec 4, 2003·Drug and Alcohol Dependence·Ronald L CowanPerry F Renshaw
Jan 22, 2004·Psychopharmacology·Michelle WareingJohn E Fisk
Apr 17, 2004·Psychopharmacology·K McCardleC Stough
Jun 15, 2004·Neuroscience Letters·Jörg DaumannEuphrosyne Gouzoulis-Mayfrank

❮ Previous
Next ❯

Citations

Jan 21, 2006·Psychopharmacology·Boris B QuednowMichael Wagner
Feb 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amy L BauernfeindRonald L Cowan
Apr 27, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerry JagerNick F Ramsey
Sep 19, 2007·Psychiatry and Clinical Neurosciences·Cheng-Fang YenSen-Yen Hsu
Nov 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Una D McCannGeorge A Ricaurte
Jul 16, 2014·Neurobiology of Learning and Memory·Andrew HawkeyMark Galizio
Feb 9, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philip KoesterJoerg Daumann
Apr 17, 2008·Neuropsychology Review·Karen A KitCatherine A Mateer
Sep 8, 2006·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Ryan M SmithDavid Q Beversdorf
Apr 18, 2009·Molecular Neurobiology·João Paulo CapelaFélix Carvalho
Jul 4, 2012·Neuroscience·P KoesterJ Daumann
Dec 24, 2015·Frontiers in Neuroscience·Daniel WagnerJoerg Daumann
Dec 8, 2009·Bioorganic & Medicinal Chemistry Letters·Onica LegendreWayne W Harding
Feb 23, 2007·Addictive Behaviors·Cheng-Fang YenChung-Ping Cheng
Mar 12, 2016·Psychological Medicine·C A RobertsC Montgomery
Oct 13, 2015·Progress in Neurobiology·Rosario MoratallaMicaela Morelli
Sep 18, 2012·Neurotoxicology·João Paulo CapelaFélix Carvalho
May 11, 2013·Neuroscience and Biobehavioral Reviews·Andrew C Parrott
Dec 30, 2014·PloS One·Jenessa S PriceKrista M Lisdahl
Nov 20, 2016·The European Journal of Neuroscience·Felix BetzlerNina Romanczuk-Seiferth
Nov 14, 2007·The Australian and New Zealand Journal of Psychiatry·Murat YücelWarrick J Brewer
Jan 19, 2010·Journal of Psychopharmacology·Ana B FagundoRafael de la Torre
Mar 3, 2006·Journal of Psychopharmacology·G J H Dumont, R J Verkes
Jan 23, 2008·Journal of Psychopharmacology·S de Sola LlopisR de la Torre
Jul 19, 2008·Journal of Psychopharmacology·K SoarJ Turner
Jul 19, 2006·Psychopharmacology·Ronald L Cowan
Mar 20, 2010·Psychopharmacology·Benjamin BeckerJörg Daumann
Jan 7, 2006·International Journal of Methods in Psychiatric Research·Maartje M L De WinWim Van den Brink
Sep 26, 2015·Pharmacological Reviews·Esa R KorpiGavin S Dawe
Jan 18, 2006·The British Journal of Psychiatry : the Journal of Mental Science·D Arnone, F Schifano
Oct 9, 2021·Experimental Neurology·Catharine Montgomery, Carl A Roberts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.